Zhejiang Medicine Co., Ltd. Class ASSE: 600216

Announcement on the Subsidiary Zhejiang Novus Pharmaceuticals Co., Ltd. Passing On-site Inspection by FDA

· Issued by Zhejiang Medicine Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on the Subsidiary Zhejiang Novus Pharmaceuticals Co., Ltd. Passing On-site Inspection by FDA

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment